Handelsavisen
prelaunch
Companies Healthcare HSTM.O
HS
HSTM.O NASDAQ Health Care Technology

Hstm.O

$28,33
Open in Charts → Attach watcher ⌖
USD
Set alert
LatestThe Week Ahead: 3 August-7 August 2026
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
838,0M USD
P/E
42,8x
EV / Rev
2,6x
Div yield
0,43 %
Op margin
7,5 %
ROE
5,6 %
Net margin
6,4 %
Debt / equity
Beta
52w range
Volume
Day range
Prev close
$28,20
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Healthstream Inc (HSTM.O) provides application software solutions, primarily within the health care technology sector, generating revenue through software licensing and related services.

Business. Healthstream Inc (HSTM.O) provides application software solutions, primarily within the health care technology sector, generating revenue through software licensing and related services.

Classification85 %
SectorHealth Care
Industry groupHealth Care Technology
Generated · model-assisted
Sell-side consensus
BUY5 analysts
2 buy3 hold0 sell
Avg 12m price target33,50

Analyst recommendations

5 analysts · consensus Buy
Buy2
Hold3
Sell0
12-month price target
33,50
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
42,8x
P/E
Analysts
Buy
5 analysts · indicative
Ownership
Dimensional Fund Advisors, L.P.
largest disclosed fund holder
Profitability
5,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

1
  • MARKETSThe Week Ahead: 3 August-7 August 20262026-08-02
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,7 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Consumer Discretionary+0,4 %+7,7 %−0,2 %
    Information Technology+0,3 %+7,8 %−0,3 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to HSTM.O. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Peers
    • EarningsQ2 2026 earnings (expected)2026-08-28 · estimated · Salesforce (CRM)
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated · ServiceNow (NOW)
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · 2026-08-02

    Composite-score breakdown

    Synthesis

    Business

    Healthstream Inc (HSTM.O) provides application software solutions, primarily within the health care technology sector, generating revenue through software licensing and related services.

    Classification85 %
    SectorHealth Care
    Industry groupHealth Care Technology
    AI synthesis
    GENERATED

    Healthstream maintains a conservative capital structure with zero debt, resulting in a debt-to-equity ratio of 0.0. The balance sheet shows total assets of $520.4 million against total equity of $354.0 million, providing a solid equity base. Liquidity is supported by $36.2 million in cash and equivalents, while operating cash flow stands at $63.3 million, significantly exceeding capital expenditures of $3.7 million. This strong free cash flow generation supports the company's low liquidity risk assessment.

    Profitability metrics indicate modest returns on capital, with a return on equity of 5.63% and a return on assets of 3.83%. The company generated $18.3 million in net income on $304.1 million in revenue, yielding a net margin of approximately 6.0%. Operating income was $20.2 million, suggesting efficient cost management relative to revenue generation. Without cohort median data for direct comparison, these returns appear stable but not exceptional for a software entity, reflecting the capital-light nature of the business model.

    Revenue concentration details by segment or geography are not provided in the available data, preventing a detailed analysis of exposure risks. The company operates within the Health Care Technology industry, which typically involves long-term contracts with healthcare providers, implying stable but potentially slow-moving revenue streams. The absence of segment data limits the ability to assess diversification benefits or specific growth drivers within the portfolio.

    Growth trajectory analysis is constrained by the absence of historical period data in the input. The current revenue base of $304.1 million provides a snapshot of scale, but year-over-year trends cannot be calculated from the provided financial snapshot alone. The company's position in the software sector suggests potential for recurring revenue models, but specific growth rates remain undisclosed in this analysis.

    Risk assessment indicates low liquidity risk and low dilution risk, with no immediate filing-based flags detected. The share count remains stable with 29.6 million basic and diluted shares outstanding, indicating no recent significant equity issuance or buyback activity. The primary risks appear to be operational and market-related rather than financial or structural, given the strong balance sheet and cash position.

    Recent observations include analyst estimates with a mean price target of $33.50, implying upside from the current market price of $28.85. The mean recommendation of 2.40 suggests a moderate buy sentiment among analysts, with one strong buy, one buy, and three hold ratings. News events reflect internal reconciler activities rather than external corporate actions, indicating no major recent disclosures or market-moving events.

    Key takeaways
    • Debt-free balance sheet with $36.2M cash provides strong financial flexibility.
    • Modest returns (ROE 5.6%, ROA 3.8%) reflect stable but not high-growth profitability.
    • Analyst consensus suggests upside potential with a mean target of $33.50 vs $28.85 price.
    • Low dilution and liquidity risks indicate a stable capital structure.
    • Lack of historical data limits growth trend analysis.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-05-04
    Q1 2026 · Quarter highlights
    Open report →

    Revenue $81.2M, +10,5% YoY; Operating income +71,6% YoY.

    Revenue$81.2M+10,5 % YoY
    Operating income$7.5M+71,6 % YoY
    Net income$5.9M+36,4 % YoY
    Free cash flow$8.8M+65,7 % YoY
    EPS
    Operating cash flow$27.1M+0,2 % YoY
    Financials
    Income statement
    Revenue$81.2M
    Gross profit$53.4M
    Operating income$7.5M
    Net income$5.9M
    Margins
    Gross margin65.8%
    Operating margin9.3%
    Net margin7.3%
    FCF margin10.8%
    Balance sheet
    Total assets$527.4M
    Total liabilities$175.4M
    Total equity$352.0M
    Cash & equivalents$48.7M
    Long-term debt$0.00
    Cash flow
    Operating cash flow$27.1M
    CapEx-$7.5M
    Free cash flow$8.8M
    SBC
    P&L flow · revenue → net income
    Revenue $81.2MOperating costs $73.7MTax $1.6MNet income $5.9M
    Highlights
    • Revenue $81.2M, +10,5% YoY
    • Operating income +71,6% YoY
    • Net income +36,4% YoY
    • Free cash flow +65,7% YoY
    • Net margin 7.3%

    Valuation TTM

    Market price
    $28,33
    Market cap
    $853.4M
    Enterprise value
    $817.2M
    P/E
    42.8x
    Non-GAAP P/E
    EV / Revenue
    2.6x
    EV / Op income
    35.0x
    EV / OCF
    12.9x
    P / B
    P / Tangible book
    Tangible book
    Net cash
    $36.2M
    Current ratio
    Debt / equity
    ROA
    3.8%
    ROE
    5.6%
    Cash conversion
    318.0%
    CapEx / revenue
    -10.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
    Vendors1

    Supply chain

    Vendors → HSTM ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSHSTMHSTMHstm.O1 entityAmazon.Com IncDepartment StoresUS
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 33 %
    EPS
    Consensus EPS
    0,75
    Predicted surprise
    -0,02
    Beat probability
    33 %
    Analysts
    5
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-07-29 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,75
    Revenueno estimateno estimate327,3M USD
    Operating incomeno estimateno estimate27,0M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution5 analysts
    Strong buy1
    Buy1
    Hold3
    Sell0
    Strong sell0
    12-month price target$33,50 · Median $33,50
    Low $27,00High $40,00
    Operating income · consensus27,0M USD
    EPS surprise
    −7,2 %
    reported vs consensus · miss
    Revenue surprise
    −7,1 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$27,00
    Mean$33,50
    Median$33,50
    High$40,00
    Spot$28,33
    +18.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    No cohort benchmark data available for this issuer yet.

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 19 279 sh42 exercises · 10 grants13 insiders
    • GORDON FRANKDirector · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
    • GORDON FRANKDirector · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
    • GORDON FRANKDirector · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
    • Taylor Tate DeborahDirector · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
    • Taylor Tate DeborahDirector · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
    • REBROVICK LINDADirector · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
    • Taylor Tate DeborahDirector · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
    • DENT THOMPSONDirector · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
    • Beard Charles Jr.Director · Restricted Share Units → Common StockDisposed 1 249exercise · 2026-06-08
    • Jahangir Amir AlexDirector · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
    • Jahangir Amir AlexDirector · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
    • MCLAREN JEFFREY LDirector · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
    • MCLAREN JEFFREY LDirector · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
    • MCLAREN JEFFREY LDirector · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
    • REBROVICK LINDADirector · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
    • RAPPUHN TERRY ALLISONDirector · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
    • RAPPUHN TERRY ALLISONDirector · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
    • RAPPUHN TERRY ALLISONDirector · Restricted Share Units → Common StockDisposed 1 016exercise · 2026-06-08
    • Jahangir Amir AlexDirector · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
    • DENT THOMPSONDirector · Restricted Share Units → Common StockDisposed 1 006exercise · 2026-06-08
    • DENT THOMPSONDirector · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
    • REBROVICK LINDADirector · Restricted Share Units → Common StockDisposed 1 126exercise · 2026-06-08
    • DENT THOMPSONDirector · Restricted Share Units → Common StockAcquired 3 654grant · 2026-05-28
    • Taylor Tate DeborahDirector · Restricted Share Units → Common StockAcquired 3 654grant · 2026-05-28
    • RAPPUHN TERRY ALLISONDirector · Restricted Share Units → Common StockAcquired 3 654grant · 2026-05-28

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Reference data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • HEALTHSTREAM INC Market data — financials · 2026-07-29
    • reconciler_enqueue (reconciler) on HSTM.O · 2026-07-29
    • HealthStream Inc Market data — analyst estimates · 2026-07-29
    • HealthStream Inc Market data — ESG · 2026-07-29
    • HSTM.O HA canonical relationships · 2026-07-29

    Ownership & reference

    Top holders

    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,01 %$30M
    • Arrowstreet Capital, Limited PartnershipInvestment Managers · as of 2026-03-310,00 %$8M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$112M
    • Principal Global Investors (Equity)Investment Managers · as of 2026-03-310,00 %$3M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$4M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$7M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$15M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$5M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$59M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$6M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$6M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$21M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$4M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • Victory Capital Management Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$2M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$8M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$2M
    • Franklin Advisers, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$4M
    • First Trust Advisors L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$1M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M

    Leadership

    • Robert A. FristChairman of the Board, Chief Executive Officer

    Insider activity

    Net selling0 buys · 4 sellsnet -$346K12 insiders · last 365d
    • REBROVICK LINDADirector · Common Stock HoldingSold 6 000 @ $29,00$174K · 2026-07-06
    • Beard Charles Jr.Director · Common Stock HoldingOther 1 249 · 2026-06-08
    • DENT THOMPSONDirector · Common Stock HoldingOther 3 148 · 2026-06-08
    • Jahangir Amir AlexDirector · Common Stock HoldingOther 3 148 · 2026-06-08
    • MCLAREN JEFFREY LDirector · Common Stock HoldingOther 3 148 · 2026-06-08
    • RAPPUHN TERRY ALLISONDirector · Common Stock HoldingOther 3 148 · 2026-06-08
    • REBROVICK LINDADirector · Common Stock HoldingOther 3 148 · 2026-06-08
    • Taylor Tate DeborahDirector · Common Stock HoldingOther 3 148 · 2026-06-08
    • GORDON FRANKDirector · Common Stock HoldingOther 3 148 · 2026-06-08
    • REBROVICK LINDADirector · Common Stock HoldingSold 2 000 @ $25,00$50K · 2026-06-01
    • REBROVICK LINDADirector · Common Stock HoldingSold 2 000 @ $25,00$50K · 2026-05-28
    • GORDON FRANKDirector · Common Stock HoldingOther 1 482 @ $24,63$37K · 2026-05-28
    • O'Hara Kevin PExecutive Vice President · Common Stock HoldingSold 3 000 @ $24,08$72K · 2026-05-20
    • Collier Michael ManningExecutive Vice President · Common Stock HoldingOther 1 774 @ $21,25$38K · 2026-03-30
    • Roberts Scott AlexanderCFO and SVP · Common Stock HoldingOther 5 601 · 2026-03-30
    • Roberts Scott AlexanderCFO and SVP · Common Stock HoldingOther 1 364 @ $21,25$29K · 2026-03-30
    • O'Hara Kevin PExecutive Vice President · Common Stock HoldingOther 1 382 @ $21,25$29K · 2026-03-30
    • O'Hara Kevin PExecutive Vice President · Common Stock HoldingOther 5 672 · 2026-03-30
    • Coady Trisha LExecutive Vice President · Common Stock HoldingOther 5 672 · 2026-03-30
    • Coady Trisha LExecutive Vice President · Common Stock HoldingOther 1 382 @ $21,25$29K · 2026-03-30
    • Collier Michael ManningExecutive Vice President · Common Stock HoldingOther 7 285 · 2026-03-30

    Short positioning

    1.2Mshares short+9.7% vs prior
    6.65days to cover
    69.9%short of daily vol
    268fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    HSTM.OCanonical
    NASDAQ · USD

    Intel & risk

    PredictorBeat prob33 %Surprise-0,02Full forecast →
    peak dispatch · 2026-08-02
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.
    Relationship graph
    HSTMMSFTCRMNOWAMZN.OHealth Care Te
    This companyPeerSectorVendors

    Evidence & claims

    From filings & derived data
    • Cash & equivalents (annual): USD 36.16MUnknown
    • Shares outstanding (annual): 29.58MUnknown
    • Total assets (annual): USD 520.37MUnknown
    • Current assets (annual): USD 119.66MUnknown
    • Revenue (annual): USD 304.06MUnknown
    • Current liabilities (annual): USD 124.15MUnknown
    • Operating income (annual): USD 20.24MUnknown
    • Shareholders' equity (annual): USD 354.02MUnknown
    • Pre-tax income (annual): USD 23.22MUnknown
    • EPS (diluted) (annual): USD-PER-SHARES 1Unknown
    • Net income (annual): USD 18.34MUnknown
    • Capex (annual): USD 3.69MUnknown
    • EPS (basic) (annual): USD-PER-SHARES 1Unknown
    • Operating cash flow (annual): USD 63.32MUnknown
    • R&D expense (annual): USD 50.98MUnknown
    • Shareholders' equity (annual): USD 359.36MUnknown
    • Operating cash flow (annual): USD 57.66MUnknown
    • Capex (annual): USD 1.4MUnknown
    • Current assets (annual): USD 153.12MUnknown
    • Total assets (annual): USD 510.77MUnknown
    • Shares outstanding (annual): 30.43MUnknown
    • Cash & equivalents (annual): USD 59.47MUnknown
    • R&D expense (annual): USD 48.89MUnknown
    • Revenue (annual): USD 291.65MUnknown
    Showing 24 of 28 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-08-03 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-08-03EVENTQ2 2026 earnings (expected) estimated date
    2026-07-06INSIDERREBROVICK LINDA sold 6.0k sh Common Stock Holding — Director ~$174k
    2026-06-08 00:00 UTCINSIDER31 insider transactions — 2026-06 22 derivative
    2026-06-08 00:00 UTCINSIDER31 insider transactions — 2026-06 22 derivative
    2026-06-08INSIDERBeard Charles Jr. transacted 1.2k sh Common Stock Holding — Director
    2026-06-08INSIDERDENT THOMPSON transacted 3.1k sh Common Stock Holding — Director
    2026-06-08INSIDERJahangir Amir Alex transacted 3.1k sh Common Stock Holding — Director
    2026-06-08INSIDERMCLAREN JEFFREY L transacted 3.1k sh Common Stock Holding — Director
    2026-06-08INSIDERRAPPUHN TERRY ALLISON transacted 3.1k sh Common Stock Holding — Director
    2026-06-08INSIDERREBROVICK LINDA transacted 3.1k sh Common Stock Holding — Director
    2026-06-08INSIDERTaylor Tate Deborah transacted 3.1k sh Common Stock Holding — Director
    2026-06-08INSIDERGORDON FRANK transacted 3.1k sh Common Stock Holding — Director
    2026-06-08INSIDERGORDON FRANK disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERGORDON FRANK disposed of 1.1k sh Restricted Share Units — Director
    2026-06-08INSIDERGORDON FRANK disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERTaylor Tate Deborah disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERTaylor Tate Deborah disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERREBROVICK LINDA disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERTaylor Tate Deborah disposed of 1.1k sh Restricted Share Units — Director
    2026-06-08INSIDERDENT THOMPSON disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERBeard Charles Jr. disposed of 1.2k sh Restricted Share Units — Director
    2026-06-08INSIDERJahangir Amir Alex disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERJahangir Amir Alex disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERMCLAREN JEFFREY L disposed of 1.1k sh Restricted Share Units — Director
    2026-06-08INSIDERMCLAREN JEFFREY L disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERMCLAREN JEFFREY L disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERREBROVICK LINDA disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERRAPPUHN TERRY ALLISON disposed of 1.1k sh Restricted Share Units — Director
    2026-06-08INSIDERRAPPUHN TERRY ALLISON disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERRAPPUHN TERRY ALLISON disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERJahangir Amir Alex disposed of 1.1k sh Restricted Share Units — Director
    2026-06-08INSIDERDENT THOMPSON disposed of 1.0k sh Restricted Share Units — Director
    2026-06-08INSIDERDENT THOMPSON disposed of 1.1k sh Restricted Share Units — Director
    2026-06-08INSIDERREBROVICK LINDA disposed of 1.1k sh Restricted Share Units — Director
    2026-06-01INSIDERREBROVICK LINDA sold 2.0k sh Common Stock Holding — Director ~$50k
    2026-05-29FILINGFORM 8-K →
    2026-05-28 00:00 UTCINSIDER13 insider transactions — 2026-05 · $159k gross 10 derivative
    Showing the 40 most recent of 75 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Reference data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage